| Market Cap | 513M 442M 415M 380M 710M 48.45B 712M 4.91B 1.91B 24.86B 1.93B 1.89B 80.09B | P/E 2017 |
-17.4x | P/E 2018 | -41.8x |
|---|---|---|---|---|---|
| Enterprise Value | 460M 396M 373M 340M 637M 43.44B 638M 4.4B 1.71B 22.29B 1.73B 1.69B 71.81B | EV / Sales 2017 |
53,919,197x | EV / Sales 2018 | 19,487,976x |
| Free-Float |
80.58% | Yield 2017 * |
-
| Yield 2018 | - |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -.--% | -8.86% | - | - | 352M | |
| +0.49% | +2.04% | -13.05% | -7.12% | 13.56B | |
| +1.17% | -1.39% | -31.19% | -56.60% | 4.93B | |
| +2.06% | -1.16% | -0.84% | -2.86% | 4.62B | |
| +0.95% | -1.92% | -1.24% | -31.51% | 3.95B | |
| -0.06% | -1.29% | -18.62% | +1.44% | 3.57B | |
| +0.82% | +2.75% | +1.02% | -1.57% | 3.53B | |
| +0.34% | -1.07% | -9.74% | +4.62% | 3.28B | |
| 0.00% | -2.11% | -21.76% | -16.34% | 2.33B | |
| -0.20% | -2.69% | -25.61% | -17.29% | 1.68B | |
| Average | +0.56% | +0.21% | -13.45% | -14.14% | 4.61B | |
| Weighted average by Cap. | +0.70% | +0.61% | -12.74% | -13.65% |
| 2017 | 2018 | |
|---|---|---|
| Net sales | 3.08 2.65 2.49 2.28 4.26 290.61 4.27 29.45 11.43 149.1 11.56 11.31 480.34 | 18.69 16.09 15.13 13.82 25.86 1.76K 25.93 178.83 69.4 905.52 70.19 68.66 2.92K |
| Net income | -8.89M -7.65M -7.2M -6.58M -12.3M -839M -12.34M -85.06M -33.01M -431M -33.39M -32.66M -1.39B | -8.41M -7.24M -6.81M -6.22M -11.64M -794M -11.67M -80.5M -31.24M -408M -31.6M -30.91M -1.31B |
| Net Debt | -1.84M -1.58M -1.49M -1.36M -2.54M -174M -2.55M -17.59M -6.83M -89.08M -6.9M -6.75M -287M | -53.08M -45.67M -42.97M -39.25M -73.43M -5.01B -73.63M -508M -197M -2.57B -199M -195M -8.28B |
Employees
-
Sector
Pharmaceuticals
